11/1/2011 | CVLM | Millipore calls 3.75% convertibles; noteholders may put, convert notes
|
12/7/2010 | BKCVHYIG | S&P lifts Millipore from junk
|
10/28/2010 | CVIG | S&P ups Millipore notes to BBB+
|
10/27/2010 | BKCVHY | Moody's lifts Millipore notes
|
10/13/2010 | BKCVHY | Moody's: Millipore notes may rise
|
7/27/2010 | CVHYLM | Millipore 3.75%, 5.875% noteholders get change-of-control put option
|
7/16/2010 | CV | Millipore holders may convert 3.75% notes following Merck acquisition
|
7/15/2010 | CVLM | Millipore amends 3.75% convertible notes following acquisition; holders may put back 5 7/8% notes
|
6/9/2010 | CV | Millipore's 3.75% convertible notes to become convertible on June 14
|
3/2/2010 | BKCVHY | S&P affirms Millipore; outlook positive
|
3/1/2010 | CV | Market Commentary: Millipore a little weaker dollar neutral, but OSI Pharma expands; Amylin, Isis also in trade
|
2/22/2010 | CV | Market Commentary: Millipore higher on potential takeout reports; Seagate steady; Trico Marine heads still lower
|
9/22/2006 | CV | Market Commentary: Priceline climbs on debut; Lions Gate jumps on stock upgrade; Novell steady amid looming default
|
7/17/2006 | BKBTCVHY | Moody's cuts Millipore to junk
|
6/28/2006 | BKBTCVHY | Moody's rates Millipore notes Ba2
|
6/23/2006 | CV | Market Commentary: Convertibles mostly quiet; Six Flags drops outright, new MedImmune issues lifted 1 point
|
6/7/2006 | BTCV | New Issue: Millipore prices $550 million 20-year convertibles within talk, at 3.75%, up 40%
|
6/7/2006 | CV | Market Commentary: Interpublic, Spansion, Charles River climb, Millipore struggles on debuts; Level 3 up in gray; L-3 gains
|
6/6/2006 | CV | Market Commentary: New deals seen as unexciting; Spansion structure seen as too long; Charles River, Millipore views mixed
|
6/6/2006 | BTCV | Millipore's $550 million of 20-year convertibles talked 3.25%-3.75%, up 37.5%-42.5%, to price Tuesday
|